HK1010139A1 - Encapsulated cells producing viral particles. - Google Patents

Encapsulated cells producing viral particles.

Info

Publication number
HK1010139A1
HK1010139A1 HK98110992A HK98110992A HK1010139A1 HK 1010139 A1 HK1010139 A1 HK 1010139A1 HK 98110992 A HK98110992 A HK 98110992A HK 98110992 A HK98110992 A HK 98110992A HK 1010139 A1 HK1010139 A1 HK 1010139A1
Authority
HK
Hong Kong
Prior art keywords
encapsulated cells
viral particles
cells producing
producing viral
genes
Prior art date
Application number
HK98110992A
Other languages
English (en)
Inventor
Robert Michael Saller
Walter H Gunzburg
Brian Salmons
Original Assignee
Bavarian Nordic As
Gsfforschungszentrum Fur Umwel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8097001&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1010139(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bavarian Nordic As, Gsfforschungszentrum Fur Umwel filed Critical Bavarian Nordic As
Publication of HK1010139A1 publication Critical patent/HK1010139A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
HK98110992A 1995-06-27 1998-09-26 Encapsulated cells producing viral particles. HK1010139A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK74095 1995-06-27
PCT/EP1996/002748 WO1997001357A1 (en) 1995-06-27 1996-06-24 Encapsulated cells producing viral particles

Publications (1)

Publication Number Publication Date
HK1010139A1 true HK1010139A1 (en) 1999-06-17

Family

ID=8097001

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110992A HK1010139A1 (en) 1995-06-27 1998-09-26 Encapsulated cells producing viral particles.

Country Status (22)

Country Link
US (1) US6776985B1 (pl)
EP (1) EP0835137B1 (pl)
JP (2) JP4119952B2 (pl)
KR (1) KR100484883B1 (pl)
CN (1) CN1187095C (pl)
AT (1) ATE309000T1 (pl)
AU (1) AU708273B2 (pl)
CA (1) CA2222559A1 (pl)
CZ (1) CZ286979B6 (pl)
DE (1) DE69633180D1 (pl)
DK (1) DK0835137T3 (pl)
ES (1) ES2253754T3 (pl)
HK (1) HK1010139A1 (pl)
IL (1) IL122119A (pl)
NO (1) NO321427B1 (pl)
NZ (1) NZ312671A (pl)
PL (1) PL185338B1 (pl)
PT (1) PT835137E (pl)
RU (1) RU2187301C2 (pl)
SI (1) SI0835137T1 (pl)
UA (1) UA65525C2 (pl)
WO (1) WO1997001357A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5103996A (en) 1995-03-09 1996-10-02 Bavarian Nordic Research Institute A/S Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
WO1997001357A1 (en) 1995-06-27 1997-01-16 Bavarian Nordic Research Institute A/S Encapsulated cells producing viral particles
PL188323B1 (pl) 1996-03-27 2005-01-31 Bavarian Nordic As Kapsuła zawierająca komórki i jej zastosowanie oraz kompozycja i środek farmaceutyczny
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
CN1266362A (zh) 1998-05-05 2000-09-13 皇家菲利浦电子有限公司 包括具有刷毛区和齿间刷毛区的毛刷件的牙刷
CN1950397B (zh) 2004-03-30 2012-05-16 Ns基因公司 生长因子NsG33的治疗用途
US20090022785A1 (en) * 2005-05-03 2009-01-22 Veterinarmedizinische Universitat Wien Permeable Capsules
CN101903049B (zh) * 2007-12-20 2014-08-13 伊西康公司 包囊的肾组织
KR101250925B1 (ko) * 2011-10-28 2013-04-04 한화케미칼 주식회사 캡슐 세포용 구조체
GB201408233D0 (en) 2014-05-09 2014-06-25 Austrianova Singapore Pte Ltd Use of polyanionic composition
KR102067352B1 (ko) * 2015-11-24 2020-01-16 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 레트로바이러스 생산을 위한 일시적인 형질감염 방법
BR112018010635A2 (pt) * 2015-11-24 2018-11-27 Glaxosmithkline Ip Dev Ltd linhagens celulares estáveis para a produção retroviral
WO2017205573A1 (en) 2016-05-25 2017-11-30 Lonza Houston Inc. Methods for isolating adeno-associated virus using a polydiallyldialkylammonium salt
RU2688383C2 (ru) * 2017-07-10 2019-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский национальный исследовательский государственный университет имени Н.Г. Чернышевского" Способ синтеза белка в культуре бактериальных клеток
CN110615667B (zh) * 2018-06-19 2022-02-15 华北理工大学 基于铁尾矿和碱渣的核壳结构陶粒及其制备方法
JP2024519909A (ja) * 2021-05-21 2024-05-21 バイオナット ラブス リミテッド マイクロボット媒介治療送達のためのシステム及び方法
CN115820683B (zh) * 2022-09-28 2024-04-05 西南大学 家蚕Cyp9a20基因及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
DD160393A3 (de) * 1980-11-14 1983-07-27 Horst Dautzenberg Mikrokapseln und verfahren zu ihrer herstellung
US4686098A (en) * 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo
US4680174A (en) * 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
EP0199362A3 (en) * 1985-04-26 1987-10-07 Massachusetts Institute Of Technology System and apparatus for delayed and pulsed release of biologically active substances
CA1310924C (en) * 1986-04-24 1992-12-01 Francis P. Mccormick Infective drug delivery system
EP0371119B1 (en) 1988-05-17 1996-09-04 Sloan-Kettering Institute For Cancer Research Retroviral vector
US5328470A (en) * 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
DE4021050A1 (de) * 1990-06-29 1992-01-02 Akad Wissenschaften Ddr Verfahren zur herstellung von mikrokapseln
CA2051288C (en) * 1990-09-14 2002-02-05 Robert L. Martuza Viral targeted destruction of neoplastic cells
JPH06500927A (ja) * 1990-12-13 1994-01-27 アメリカ合衆国 高力価の組換えウイルスベクターおよび遺伝子療法に用いられる形質導入標的細胞の持続的及び連続的生産
WO1994029437A1 (en) 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
US5688773A (en) 1994-08-17 1997-11-18 The General Hospital Corporation Method of selectively destroying neoplastic cells
HU221607B (hu) 1994-09-02 2002-11-28 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH. Önmagukat nem inaktiváló, célzott expressziót biztosító retrovírusvektorok
WO1997001357A1 (en) 1995-06-27 1997-01-16 Bavarian Nordic Research Institute A/S Encapsulated cells producing viral particles
ES2174103T3 (es) 1995-09-06 2002-11-01 Austrian Nordic Biotherapeutic Uso de las secuencias reguladoras de wap o mmtv para expresion dirigida de genes heterologos ligados en celulas mamarias humanas, con inclusion de celulas de carcinoma mamario humano.
PL188323B1 (pl) 1996-03-27 2005-01-31 Bavarian Nordic As Kapsuła zawierająca komórki i jej zastosowanie oraz kompozycja i środek farmaceutyczny

Also Published As

Publication number Publication date
CN1189104A (zh) 1998-07-29
WO1997001357A1 (en) 1997-01-16
NO975813D0 (no) 1997-12-10
AU708273B2 (en) 1999-07-29
RU2187301C2 (ru) 2002-08-20
DE69633180D1 (de) 2004-09-23
CZ286979B6 (en) 2000-08-16
UA65525C2 (en) 2004-04-15
KR19990028491A (ko) 1999-04-15
AU6415496A (en) 1997-01-30
DK0835137T3 (da) 2006-03-06
IL122119A0 (en) 1998-04-05
PT835137E (pt) 2004-12-31
NO975813L (no) 1998-02-23
PL185338B1 (pl) 2003-04-30
JP4848348B2 (ja) 2011-12-28
EP0835137A1 (en) 1998-04-15
CZ419597A3 (cs) 1998-03-18
NZ312671A (en) 1999-10-28
NO321427B1 (no) 2006-05-08
KR100484883B1 (ko) 2005-09-02
PL324289A1 (en) 1998-05-11
US6776985B1 (en) 2004-08-17
ATE309000T1 (de) 2005-11-15
JPH11508768A (ja) 1999-08-03
SI0835137T1 (sl) 2006-04-30
JP2008101011A (ja) 2008-05-01
CN1187095C (zh) 2005-02-02
JP4119952B2 (ja) 2008-07-16
ES2253754T3 (es) 2006-06-01
IL122119A (en) 2004-06-01
CA2222559A1 (en) 1997-01-16
EP0835137B1 (en) 2005-11-09

Similar Documents

Publication Publication Date Title
IL122119A0 (en) Encapsulated cells producing viral particles
CA2092195A1 (en) Retroviral packaging cell line
AU6871398A (en) Method for enhancing expression of a foreign or endogenous gene product in pla nts
CA2130454A1 (en) Production of viral resistant plants via introduction of untranslatable plus sense viral rna
CA2182303A1 (fr) Procede de preparation d'un vecteur viral par recombinaison homologue intermoleculaire
KR970700771A (ko) 비-바이러스 벡터(Non-viral vector)
IL123833A0 (en) Vector and method of use for nucleic acid delivery to non-dividing cells
GB9813540D0 (en) Chemical compounds
WO1996019568A3 (en) Stabilized ribozyme analogs
CA2154023A1 (en) Recombinant infectious non-segmented negative strand rna virus
MY116535A (en) New stable pharmaceutical preparation for producing propellant gas-free aerosols
AU6933496A (en) Antagonists of the oncogenic activity of the MDM2 protein and their use in the treatment of cancers
AU1022999A (en) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
ZA983851B (en) Substituted 3,3-diamino-2-propenenitriles their preparation and use
WO1990006943A3 (de) Neue tnf-peptide
PL329071A1 (en) Retroviral vector transducing the p 45 cytochrome gene
AU3390995A (en) Novel implant and novel vector for the treatment of acquired diseases
AU4903099A (en) Targeted integration into chromosomes using retroviral vectors
WO1996033282A3 (en) High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
ZA986336B (en) Medicaments comprising polyhydroxybutylpyrazines novel polyhydroxybutylpyrazines and their preparation
CA2331440A1 (en) Amphotropic retrovirus packaging cell line, process for its production and use thereof
OA09197A (fr) "Peptides SDK, leur procédé de préparation ainsi que des compositions thérapeutiques en contenant".
WO1988004666A3 (en) Lung cytotoxic peptides
PT1173471E (pt) Análogos de pseudomicinas
AU1275095A (en) Antiviral composition of viral protein trans-dominant variants

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110624